Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Toxicol Pathol ; 58(6): 375-82, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17408938

ABSTRACT

To evaluate new-drugs potential for phospholipidosis (PL), we developed a cell-based fluorescence assay using a fluorescent-labeled phospholipid analogue (NBD-PE). CHL/IU cells derived from newborn hamster lung were exposed to positive reference compounds (amiodarone, imipramine, chloroquine, propranolol, chlorpromazine and amantadine) in the presence of NBD-PE, and the level of PL, as indicated by accumulation of fluorescent inclusions in the cytoplasm, was evaluated using fluorescence microscopy and fluorometry. All positive reference compounds induced accumulation of fluorescent inclusions in a concentration-dependent manner with an increase in fluorescence intensity. Fluorescence microscopically, the positive dose of test compound was determined as the concentration with a grade equivalent to or above that of 3.13 microM of amiodarone. Based on this criterion, 8 of 20 test compounds including PL-positive or -negative compounds were judged positive that were concurrent with the pathological results from rat toxicity studies. Furthermore, a positive criterion for fluorometry was decided as equivalent to or above 25% of maximum intensity induced by 1.56-25.0 microM amiodarone. In comparison of fluorometry methods with fluorescence microscopy method, 19 of 20 compounds were judged same. From these findings, we concluded that the assay developed in this study is a rapid and reliable method to predict new-drugs potential for PL at an early stage of drug development.


Subject(s)
Drug Evaluation, Preclinical/methods , Drug-Related Side Effects and Adverse Reactions , Fluorescent Dyes/pharmacology , Lipidoses/chemically induced , Phosphatidylethanolamines/pharmacology , Phospholipids/metabolism , Animals , Animals, Newborn , Cell Line , Cell Survival/drug effects , Cricetinae , Cricetulus , Dose-Response Relationship, Drug , Drug Combinations , Inclusion Bodies/drug effects , Inclusion Bodies/metabolism , Inclusion Bodies/ultrastructure , Lipidoses/metabolism , Lung/drug effects , Lung/metabolism , Lung/ultrastructure , Male , Microscopy, Confocal , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Pharmaceutical Preparations/classification , Rats , Rats, Sprague-Dawley , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL
...